LAURA BUCK: Open Payments
NPI 1346524519 · PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,246 in 47 payments from 10 companies in 2025. Trend: 2023 $3,509 · 2024 $838 · 2025 $2,246
Food & beverage: $2,246
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $654 |
| PFIZER INC. | 11 | $387 |
| ABBVIE INC. | 18 | $263 |
| Amgen Inc. | 2 | $241 |
| SK Life Science, Inc. | 2 | $213 |
| Lundbeck LLC | 2 | $154 |
| Grifols USA, LLC | 1 | $127 |
| Neurocrine BioSciences, Inc. | 1 | $112 |
| Neurelis, Inc. | 1 | $62 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: Fintepla, ZAVZPRET, QULIPTA, NURTEC ODT, VYEPTI, Gamunex-C, XCOPRI, UPLIZNA.
Industry payments across NY — which companies pay providers there.
